BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

632 related articles for article (PubMed ID: 33556642)

  • 21. Upregulation of Alzheimer's Disease Amyloid-β Protein Precursor in Astrocytes Both in vitro and in vivo.
    Liang Y; Raven F; Ward JF; Zhen S; Zhang S; Sun H; Miller SJ; Choi SH; Tanzi RE; Zhang C
    J Alzheimers Dis; 2020; 76(3):1071-1082. PubMed ID: 32597805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Role of Low-Density Lipoprotein Receptor-Related Protein 4 (LRP4) in Astrocytic Aβ Clearance.
    Zhang H; Chen W; Tan Z; Zhang L; Dong Z; Cui W; Zhao K; Wang H; Jing H; Cao R; Kim C; Safar JG; Xiong WC; Mei L
    J Neurosci; 2020 Jul; 40(28):5347-5361. PubMed ID: 32457076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calcineurin/NFAT Signaling in Activated Astrocytes Drives Network Hyperexcitability in Aβ-Bearing Mice.
    Sompol P; Furman JL; Pleiss MM; Kraner SD; Artiushin IA; Batten SR; Quintero JE; Simmerman LA; Beckett TL; Lovell MA; Murphy MP; Gerhardt GA; Norris CM
    J Neurosci; 2017 Jun; 37(25):6132-6148. PubMed ID: 28559377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer's disease.
    Watanabe K; Uemura K; Asada M; Maesako M; Akiyama H; Shimohama S; Takahashi R; Kinoshita A
    Mol Brain; 2015 Dec; 8(1):82. PubMed ID: 26637371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deficient astrocyte metabolism impairs glutamine synthesis and neurotransmitter homeostasis in a mouse model of Alzheimer's disease.
    Andersen JV; Christensen SK; Westi EW; Diaz-delCastillo M; Tanila H; Schousboe A; Aldana BI; Waagepetersen HS
    Neurobiol Dis; 2021 Jan; 148():105198. PubMed ID: 33242587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impairment of Glycolysis-Derived l-Serine Production in Astrocytes Contributes to Cognitive Deficits in Alzheimer's Disease.
    Le Douce J; Maugard M; Veran J; Matos M; Jégo P; Vigneron PA; Faivre E; Toussay X; Vandenberghe M; Balbastre Y; Piquet J; Guiot E; Tran NT; Taverna M; Marinesco S; Koyanagi A; Furuya S; Gaudin-Guérif M; Goutal S; Ghettas A; Pruvost A; Bemelmans AP; Gaillard MC; Cambon K; Stimmer L; Sazdovitch V; Duyckaerts C; Knott G; Hérard AS; Delzescaux T; Hantraye P; Brouillet E; Cauli B; Oliet SHR; Panatier A; Bonvento G
    Cell Metab; 2020 Mar; 31(3):503-517.e8. PubMed ID: 32130882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GABAB Receptor-Mediated PI3K/Akt Signaling Pathway Alleviates Oxidative Stress and Neuronal Cell Injury in a Rat Model of Alzheimer's Disease.
    Sun Z; Sun L; Tu L
    J Alzheimers Dis; 2020; 76(4):1513-1526. PubMed ID: 32651311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of microRNA-34a in Alzheimer's disease brain targets genes linked to synaptic plasticity, energy metabolism, and resting state network activity.
    Sarkar S; Jun S; Rellick S; Quintana DD; Cavendish JZ; Simpkins JW
    Brain Res; 2016 Sep; 1646():139-151. PubMed ID: 27235866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Energy metabolism in astrocytes: high rate of oxidative metabolism and spatiotemporal dependence on glycolysis/glycogenolysis.
    Hertz L; Peng L; Dienel GA
    J Cereb Blood Flow Metab; 2007 Feb; 27(2):219-49. PubMed ID: 16835632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activity-dependent neuronal Klotho enhances astrocytic aerobic glycolysis.
    Mazucanti CH; Kawamoto EM; Mattson MP; Scavone C; Camandola S
    J Cereb Blood Flow Metab; 2019 Aug; 39(8):1544-1556. PubMed ID: 29493420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ultrasound-mediated augmented exosome release from astrocytes alleviates amyloid-β-induced neurotoxicity.
    Deng Z; Wang J; Xiao Y; Li F; Niu L; Liu X; Meng L; Zheng H
    Theranostics; 2021; 11(9):4351-4362. PubMed ID: 33754065
    [No Abstract]   [Full Text] [Related]  

  • 32. Semaglutide ameliorates cognition and glucose metabolism dysfunction in the 3xTg mouse model of Alzheimer's disease via the GLP-1R/SIRT1/GLUT4 pathway.
    Wang ZJ; Li XR; Chai SF; Li WR; Li S; Hou M; Li JL; Ye YC; Cai HY; Hölscher C; Wu MN
    Neuropharmacology; 2023 Dec; 240():109716. PubMed ID: 37730113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycolytic preconditioning in astrocytes mitigates trauma-induced neurodegeneration.
    Solano Fonseca R; Metang P; Egge N; Liu Y; Zuurbier KR; Sivaprakasam K; Shirazi S; Chuah A; Arneaud SL; Konopka G; Qian D; Douglas PM
    Elife; 2021 Sep; 10():. PubMed ID: 34473622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DA5-CH, a novel GLP-1/GIP dual agonist, effectively ameliorates the cognitive impairments and pathology in the APP/PS1 mouse model of Alzheimer's disease.
    Cao Y; Hölscher C; Hu MM; Wang T; Zhao F; Bai Y; Zhang J; Wu MN; Qi JS
    Eur J Pharmacol; 2018 May; 827():215-226. PubMed ID: 29551659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Astrocytic α7 Nicotinic Receptor Activation Inhibits Amyloid-β Aggregation by Upregulating Endogenous αB-crystallin through the PI3K/Akt Signaling Pathway.
    Ren Z; Yang M; Guan Z; Yu W
    Curr Alzheimer Res; 2019; 16(1):39-48. PubMed ID: 30345917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurons rely on glucose rather than astrocytic lactate during stimulation.
    Díaz-García CM; Yellen G
    J Neurosci Res; 2019 Aug; 97(8):883-889. PubMed ID: 30575090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The expression and activity of K
    Boscia F; Pannaccione A; Ciccone R; Casamassa A; Franco C; Piccialli I; de Rosa V; Vinciguerra A; Di Renzo G; Annunziato L
    Neurobiol Aging; 2017 Jun; 54():187-198. PubMed ID: 28390823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clusterin secreted from astrocyte promotes excitatory synaptic transmission and ameliorates Alzheimer's disease neuropathology.
    Chen F; Swartzlander DB; Ghosh A; Fryer JD; Wang B; Zheng H
    Mol Neurodegener; 2021 Jan; 16(1):5. PubMed ID: 33517893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GJA1 (connexin43) is a key regulator of Alzheimer's disease pathogenesis.
    Kajiwara Y; Wang E; Wang M; Sin WC; Brennand KJ; Schadt E; Naus CC; Buxbaum J; Zhang B
    Acta Neuropathol Commun; 2018 Dec; 6(1):144. PubMed ID: 30577786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neural activity triggers neuronal oxidative metabolism followed by astrocytic glycolysis.
    Kasischke KA; Vishwasrao HD; Fisher PJ; Zipfel WR; Webb WW
    Science; 2004 Jul; 305(5680):99-103. PubMed ID: 15232110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.